Cargando…
Estrogen Receptor-Regulated Gene Signatures in Invasive Breast Cancer Cells and Aggressive Breast Tumors
SIMPLE SUMMARY: Metastatic breast cancer remains a major clinical problem, contributing to significant patient mortality, which is partly due to a lack of understanding around the early changes within the primary tumor. Tumors frequently become more aggressive and less treatable due to the activatio...
Autores principales: | Smart, Emily, Semina, Svetlana E., Alejo, Luis H., Kansara, Nidhi S., Frasor, Jonna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221274/ https://www.ncbi.nlm.nih.gov/pubmed/35740514 http://dx.doi.org/10.3390/cancers14122848 |
Ejemplares similares
-
Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors
por: Semina, Svetlana E., et al.
Publicado: (2022) -
Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells
por: Semina, Svetlana E., et al.
Publicado: (2022) -
Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas
por: Emmadi, Rajyasree, et al.
Publicado: (2015) -
PHLDA1 Expression is Controlled by an Estrogen Receptor (ER)-NFκB-miR-181 Regulatory Loop and is Essential for Formation of ER+ Mammospheres
por: Kastrati, Irida, et al.
Publicado: (2014) -
THU486 Identification Of Metabolic And Molecular Mechanisms Driving Estrogen Receptor Positive Breast Cancer Disparities Using A Machine-Learning Pipeline
por: Casiano, Ashlie Santaliz, et al.
Publicado: (2023)